21 related articles for article (PubMed ID: 21627359)
1. p16 and p53 can Serve as Prognostic Markers for Head and Neck Squamous Cell Carcinoma.
Wang Y; Wang F; Wang S; Zhang L; Fu H; Sun L; Wang W; Liu C; Ren W; Gao L; Xing G; Ma X
Int Dent J; 2024 Jun; 74(3):543-552. PubMed ID: 38105167
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.
Galloway TJ; Zhang QE; Nguyen-Tan PF; Rosenthal DI; Soulieres D; Fortin A; Silverman CL; Daly ME; Ridge JA; Hammond JA; Le QT
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):362-371. PubMed ID: 27478170
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancer.
Hung TKW; Ho AL; Pfister DG
J Surg Oncol; 2021 Nov; 124(6):952-961. PubMed ID: 34585389
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.
Magnes T; Wagner S; Kiem D; Weiss L; Rinnerthaler G; Greil R; Melchardt T
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067112
[TBL] [Abstract][Full Text] [Related]
5. p16, pRb, and p53 in Feline Oral Squamous Cell Carcinoma.
Supsavhad W; Dirksen WP; Hildreth BE; Rosol TJ
Vet Sci; 2016 Aug; 3(3):. PubMed ID: 29056726
[TBL] [Abstract][Full Text] [Related]
6. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
7. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy.
Higuchi E; Oridate N; Homma A; Suzuki F; Atago Y; Nagahashi T; Furuta Y; Fukuda S
Head Neck; 2007 Oct; 29(10):940-7. PubMed ID: 17563903
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
[TBL] [Abstract][Full Text] [Related]
10. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
11. High p16 expression predicts a positive response to chemoradiotherapy in stage IVa/b head and neck squamous cell carcinoma.
Chen YJ; Rau KM; Chien CY; Fang FM; Huang TL; Chiu TJ
Asian Pac J Cancer Prev; 2011; 12(3):649-55. PubMed ID: 21627359
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
